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reference in its entirety.
FIELD OF THE INVENTION
The invention relates to syringes and may be particularly suitable for syringes
that inject medicaments into joint spaces.
BACKGROUND OF THE INVENTION
It is routine in the course of treating musculoskeletal complaints, injuries, and
disease to utilize injections of several types for the relief of pain and inflammation or
to promote cartilage repair. Injection types include steroid injection, local anesthetics,
hyaluronic acid, or mixtures of the above. One aspect of performing this injection is
the proper location of the injected fluid. Unfortunately, some health care providers
perform numerous injections with limited knowledge and training in surface anatomy,
tissue planes, and musculoskeletal compartments. This knowledge can be the
difference in successful diagnosis, treatment, and often pain relief for the suffering
patient. While a basic understanding of deep and surface anatomy is required for
success, proper injection technique often affords the highest rate of success.
The ability to sense the nature of the space into which one is injecting can be
important to successful location of the chosen fluid. An experienced operator can
typically sense the nature of the tissue he or she is injecting into by interpretations of
the excursion rate and fluid resistance he or she feels while pressing on the plunger of
the syringe. For example, if the tip of the injecting needle is buried in the substance
of a tendon, the operator will encounter high resistance and very limited flow of the
fluid. If however, the needle tip is located in a joint space, the fluid will flow easily
with limited resistance. This tactile ability is not particularly intuitive and is
dependent on proper equipment as well as operator skill. For instance, many
providers will choose to use the smallest bore needle available (on the assumption that
it will cause less pain), but the resistance from a 25 gauge needle can be enough to
negate one's ability to sense the nature of the tissues into which the fluid is directed.
Switching to a larger needle, e.g., a 2 1 gauge needle, permits the desired sensing
feedback to an experienced operator while causing minimally increased discomfort
from using a slightly larger needle. However, the size of the syringe can cause
variations in the tactile response/sensing of the injection.
Routinely, the operator is looking to inject into an anatomical cavity where the
resistance is much less that an injection directly into a tissue. A device can assist the
untrained, inexperienced, or tactilely-challenged operator in sensing this location may
provide significant benefit to the patient.
SUMMARY OF EMBODIMENTS OF THE INVENTION
Embodiments of the present invention are directed to syringes that can provide
visual or audio location feedback to a user in substantially real-time to facilitate the
proper site delivery of medicament to a desired location in the body.
Some embodiments are directed to syringe assemblies that include a syringe
with a syringe body defining a fluid cavity in fluid communication with an injection
needle; a force, pressure and/or flow sensor in fluid communication with the needle;
and a user feedback unit in electrical communication with the sensor and configured
to provide user feedback based on data from the force, pressure and/or flow sensor.
The user data feedback unit can include a housing having a light indicator
whereby in operation the housing generates a green light if the needle is in a suitable
location for injection. The housing can be configured to releasably engage the syringe
body. The housing can be configured to slidably snugly receive a portion of the
syringe therein. The user feedback unit can be attached to the syringe.
In some embodiments, the housing or syringe body can include a digital signal
processor circuit configured to calculate an index of resistance associated with the
location of the needle in a patient with a low index of resistance indicating a desired
injection site. The sensor can be configured to wirelessly communicate the digital
signal processor circuit.
Some embodiments are directed to orthopedic syringes used to treat
musculoskeletal complaints, injuries, pain and/or disease to joints. Particular
embodiments are directed to syringes used to inject anti-inflammatory agents, such as
corticosteroids and/or hyaluronic acid, and/or to injectsubcutaneously into joint cavity
spaces, such as knee joints, shoulder joints, elbow joints, finger joints and the like.
Embodiments of the invention provide syringes that can calculate a resistance
index associated with an excursion flow rate into a subject and generate a visible
confirmation that the syringe needle is in the correct target space by generating, for
example, a "green" light.
Embodiments of the invention may comprise a shell or outer casing that
communicates with a disposable syringe. The shell or outer casing can comprise at
least one visual indicator light that can alert a user as to whether the syringe is in the
proper location. The syringe can include a pressure or force sensor that wirelessly
communicates with the shell or casing to generate the visual confirmation of correct
location.
Some embodiments of the invention may comprise a syringe system including
a syringe with a syringe body defining a fluid cavity and having a plunger in the fluid
cavity. The fluid cavity can be in fluid communication with an injection needle. A
plunger force sensor can be configured to detect a force exerted on the plunger by a
user. A displacement sensor can be configured to detect a displacement of the
plunger. A user feedback unit can be in communication with the plunger force sensor
and the displacement sensor and can be configured to provide user feedback based on
data from the force and/or flow sensor.
Some embodiments of the invention may comprise a syringe sensor system
configured to releasably attach to a syringe with a syringe body defining a fluid cavity
and having a plunger in the fluid cavity. The fluid cavity can be in fluid
communication with an injection needle. The syringe sensor system can include at
least one housing configured to releasably attach to the syringe. A plunger force
sensor can be on the at least one housing and can be configured to detect a force
exerted on the plunger by a user. A displacement sensor can be on the at least one
housing and can be configured to detect a displacement of the plunger. A user
feedback unit can be in electrical communication with the plunger force sensor and
the displacement sensor and configured to provide user feedback based on data from
the force and/or flow sensor.
Some embodiments of the invention may comprise methods for selecting a
tissue region for injection with a syringe in communication with an injection needle.
A force, pressure and/or flow associated with the syringe and/or injection needle can
be detected during insertion of the needle and/or during injection of a fluid through
the needle. User feedback can be provided responsive to the detected force, pressure
and/or flow.
Embodiments of the invention provide syringes that can be easy to use, and
even by patients, for chronic injections with disposable syringes that cooperate with a
reusable ergonomic housing, shell or casing. Embodiments of the invention provide
syringes that can be used as a teaching aid for nurses, doctors or other clinicians to
"learn" the correct anatomical delivery space by teaching the user the tactile feel of
the correct anatomical delivery space by associating the tactile feel with the digital
confirmation of location based on the syringe's capacity to digitally monitor pressure
and/or flow rate and/or calculate a resistance index, then provide substantially real¬
time feedback to a user.
It is noted that any of the features claimed with respect to one type of claim,
such as a system, apparatus, or computer program, may be claimed or carried out as
any of the other types of claimed operations or features.
Further features, advantages and details of the present invention will be
appreciated by those of ordinary skill in the art from a reading of the figures and the
detailed description of the embodiments that follow, such description being merely
illustrative of the present invention.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a schematic illustration of a syringe with a "smart" readout or alert
that confirms that the needle is in a proper anatomical space according to
embodiments of the present invention.
Figures 2A and 2B are partial schematic illustrations of user feedback
configurations that provide an indication of proper injection location of a needle in
substantially real-time according to embodiments of the present invention.
Figures 3A-3C are schematic illustrations of syringe delivery systems with
user feedback according to embodiments of the present invention.
Figure 4 is a perspective view of a syringe system according to embodiments
of the present invention.
Figure 5 is a reusable plunger housing of the syringe system of Figure 4.
Figure 6 is a reusable syringe housing of the syringe system of Figure 4.
Figure 7 is a graph of the voltage as a function of force of a plunger force
sensor on the syringe system of Figure 4 for calibration according to embodiments of
the present invention.
Figure 8 is a graph of the displacement as a function of voltage for a
displacement sensor on the syringe system of Figure 4 for calibration according to
embodiments of the present invention.
Figure 9 is a graph of the force and displacement as a function of time for
joint tissue according to embodiments of the present invention.
Figure 10 is a graph of the force and displacement as a function of time for
tendon tissue according to embodiments of the present invention.
Figure 11 is a scatter plot of the pressure as a function of flow-rate for tendon
and joint tissue as a function of time.
DETAILED DESCRIPTION
The present invention now is described more fully hereinafter with reference
to the accompanying drawings, in which embodiments of the invention are shown.
This invention may, however, be embodied in many different forms and should not be
construed as limited to the embodiments set forth herein; rather, these embodiments
are provided so that this disclosure will be thorough and complete, and will fully
convey the scope of the invention to those skilled in the art.
Like numbers refer to like elements throughout. In the figures, the thickness
of certain lines, layers, components, elements or features may be exaggerated for
clarity. Broken lines illustrate optional features or operations unless specified
otherwise.
The terminology used herein is for the purpose of describing particular
embodiments only and is not intended to be limiting of the invention. As used herein,
the singular forms "a," "an" and "the" are intended to include the plural forms as well,
unless the context clearly indicates otherwise. It will be further understood that the
terms "comprises" and/or "comprising," when used in this specification, specify the
presence of stated features, integers, steps, operations, elements, and/or components,
but do not preclude the presence or addition of one or more other features, integers,
steps, operations, elements, components, and/or groups thereof. As used herein, the
term "and/or" includes any and all combinations of one or more of the associated
listed items. As used herein, phrases such as "between X and Y" and "between about
X and Y" should be interpreted to include X and Y. As used herein, phrases such as
"between about X and Y" mean "between about X and about Y." As used herein,
phrases such as "from about X to Y" mean "from about X to about Y."
Unless otherwise defined, all terms (including technical and scientific terms)
used herein have the same meaning as commonly understood by one of ordinary skill
in the art to which this invention belongs. It will be further understood that terms,
such as those defined in commonly used dictionaries, should be interpreted as having
a meaning that is consistent with their meaning in the context of the specification and
relevant art and should not be interpreted in an idealized or overly formal sense unless
expressly so defined herein. Well-known functions or constructions may not be
described in detail for brevity and/or clarity.
It will be understood that when an element is referred to as being "on,"
"attached" to, "connected" to, "coupled" with, "contacting," etc., another element, it
can be directly on, attached to, connected to, coupled with or contacting the other
element or intervening elements may also be present. In contrast, when an element
is referred to as being, for example, "directly on," "directly attached" to, "directly
connected" to, "directly coupled" with or "directly contacting" another element, there
are no intervening elements present. It will also be appreciated by those of skill in
the art that references to a structure or feature that is disposed "adjacent" another
feature may have portions that overlap or underlie the adjacent feature.
It will be understood that, although the terms first, second, etc. may be used
herein to describe various elements, components, regions, layers and/or sections,
these elements, components, regions, layers and/or sections should not be limited by
these terms. These terms are only used to distinguish one element, component,
region, layer or section from another region, layer or section. Thus, a first element,
component, region, layer or section discussed below could be termed a second
element, component, region, layer or section without departing from the teachings of
the present invention. The sequence of operations (or steps) is not limited to the
order presented in the claims or figures unless specifically indicated otherwise.
The term "excursion" rate refers to the discharge or flow rate of the liquid
medicament out of the syringe body and/or needle into local anatomical structure.
The term "electrical communication" as used herein includes both wired and
wireless communication between elements.
As shown in Figure 1, the medical device 10 includes an injection syringe 15
with a plunger 15a and a syringe body 15b in communication with a user feedback
unit 22. As shown in Figure 1, the syringe body 15b is in fluid communication with
a needle 25, and the needle 25 is in fluid communication with at least one sensor 30
such as a force, pressure and/or flow sensor. The device 10 further includes a syringe
housing 20. The at least one sensor 30 can include both pressure (or force) sensor and
a flow sensor (such as flow meter). The at least one sensor 30 can be held on the
housing 20 and/or be incorporated into the syringe body 15b.
The sensor 30 can wirelessly communicate with a digital signal processing
circuit 50 that can be incorporated into the housing 20 and/or a discrete local or
remote computer device 23 (Figures 3A-3C) and, when used, the remote computer
device 23 can wirelessly transmit the user feedback signal to the "onboard" user
feedback unit 22.
In this configuration, when the needle 25 is inserted into different types of
body tissue Tl, T2, and T3, the output from the sensor(s) 30 can be used to provide
user feedback via the user feedback unit 22 to indicate when the desired insertion
location has been reached. For example, T l may be fat tissue, T2 may be muscle or
tendon tissue, and T3 may be a joint cavity, and the desired needle insertion location
may be the joint cavity (T3).
The user feedback unit 22 can include a light indicator or display and can be
held in a case (e.g., housing) 20 attached to the syringe body 15b as shown in Figure
1. In some embodiments, as shown in Figure 3A, the user feedback unit 22 may
reside in or comprise a discrete remote or local pervasive computing device 23, such
as a wireless communication device, such as, for example, a cellular wireless
telephone or PDA, and/or a laptop or other computer that communicates with the at
least one sensor 30. The device 10 can also be configured to include one or both of
the on-board user feedback unit 22 and a display in the computer device 23. As
shown in Figure 3B, the device 10 can include a casing or housing 20 with a light
emitter that provides the user feedback unit 22 with light and the user feedback unit
22 wirelessly communicates with the computer device 23 which directs the
appropriate output by the user feedback unit 22.
Again, as shown in Figure 1, the user feedback unit 22 is held by or attached
to the housing 20. The housing 20 can be lightweight and ergonomic and can
releasbly snugly slidably or frictionally serially engage different syringes 15. The
housing 20 can be compact and cover only a portion of a syringe body 15b, thereby
allowing a user visual contact with the syringe fluid in the cavity of the syringe body.
The housing 20 can be multi-use while the syringes 15 can be single-use disposable.
The housing 20 may optionally omit a user feedback indicator or member. In certain
embodiments, as shown in Figure 3C, the syringe 15 may be configured with the at
least one sensor 30 integrated therein or thereon and can include a wireless
transmission circuit 30c to communicate with at least one portable communications
device 23 (shown as two) without requiring an additional housing component.
The housing 20 can be configured as a lightweight balanced device that does
not provide eccentric weight or unbalance or unduly affect the injection operation.
The user feedback unit 22 can provide visual or audio feedback to a user in
substantially real-time to confirm or alert a user as to the proper or improper position
of the needle in situ. The user feedback unit 22 can be provided as part of the housing
20 or as a separate device. As shown in Figure 2A, the user feedback unit 22 can
comprise side-by-side LEDs (green and red or other suitable colors). In operation, a
"green" LED light can be activated when appropriate to inject based on pressure and
flow feedback and/or the index of resistance. Alternatively, a single LED could be
used whereby no light would indicate either a "go" or "no go" position of the needle
per instructions and training. As shown in Figure 2B, other user feedback units 22
may be used such as, for example, a small integrated display that can generate visual
and/or audio output to a user in substantially real-time, e.g., a. musical note or tone for
yes or no, or actual words such as "stop," "yes," "no," "go," "okay," etc. may be
output as either an audio output, as a visible readable output or both.
Figure 1 also illustrates that the device 10 can include a digital processor
circuit 50 that can be in electrical communication with the sensor 30. The digital
processor circuit 50 can be held on the syringe integral with a sensor circuit 30 (e.g.,
be "onboard" with the syringe), but is typically held in the housing 20 and/or in a local
or remote computer device 23 (Figures 3A-3C). The digital processor circuit 50 can
wirelessly communicate with the sensor 30 to obtain the desired sensor data. The
circuit 50 and/or the sensor 30 can include a pressure monitor 51. The circuit 50 can
comprise computer readable program code configured to programmatically direct the
user feedback and may calculate an index of flow resistance 52 whereby a low index
of resistance value confirms that the needle 25 is in a proper anatomical location, such
as a desired joint space. In contrast, a high index of resistance indicates an improper
location (e.g., in a tendon rather than a joint space). Other measures of flow or
resistance may be used.
Thus, in some embodiments, the syringe assembly 10 can comprise a
computer device 23 that calculates and/or measures resistance and/or calculates an
index of resistance and flow in order to alert a user as to location of the needle relative
to a comparison with a desired range of these parameters for proper placement of an
injected fluid. The syringe assembly 10 can have an outer shell or housing 20 to
which disposable syringes and needles could be attached. A clearly visible user
feedback indicator member 22 (e.g., red light, green light) on the housing 20 could
then signal the conditions for fluid injection.
The wireless communication between the electronic components can be
carried out using a BLUETOOTH transmission configuration or any other suitable
digital communication protocol or configuration. Virtual reality position sensing can
also be utilized depending on cost factors. The device 10 can be configured as an
easy-to-use and economical medical tool to promote more reliable and accurate
injection of medicament to a target space.
Any suitable sensor or combination of sensors can be used for the sensor 30.
Embodiments according to the present invention will now be described with respect to
the following non-limiting examples.
Example 1
As illustrated in Figures 4-6, a syringe system 100 includes a syringe 115 with
a syringe plunger 115a in a syringe body 115b, which is in communication with a
needle 125. Two support members or housings 120a, 120b are configured to connect
sensors 130a, 130b to the syringe 115. The sensor 130a is a force sensor configured
to detect an amount of force with which the user depresses the plunger 115a. As
illustrated in Figure 4, the sensor 130a is connected to the plunger 115a by the
housing 120b. The sensor 130b is a displacement sensor that is in communication
with the plunger 115a and detects the displacement of the plunger 115a as the user
depresses the plunger 115a.
In operation, the force sensor 130a detects the force that the user applies to the
plunger 115a, and the displacement sensor 130b detects the displacement of the
plunger 115a as the plunger 115a is depressed. Accordingly, the sensors 130a, 130b
are positioned on the outside components of the syringe 115 such that the sensors
130a, 130b do not contact the fluid in the syringe 115, and modification to the syringe
115 may be reduced or eliminated.
The force information from the sensor 130a can be converted into fluid
pressure information because the fluid pressure can be calculated as the force divided
by the relevant area. The displacement information from the sensor 130b can be
converted into flow information by calculating the volume of fluid displaced by the
plunger 115a and dividing by the time during which the displacement occurs. The
sensors 130a, 130b detect force and displacement information, for example, when the
user makes a relatively small test injection. The pressure and flow readings from the
sensors 130a, 130b can then be converted into tissue impedance, e.g., by the computer
device 23 and relayed to the user via the user feedback indicator unit 22 as discussed
with respect to Figures 1-3. If the user feedback indicator unit 22 indicates that the
desired location has been reached based on the tissue impedance, then the user can
continue with a full injection. If the desired location has not been reached, the user
can maneuver the needle 125 to another location and deliver another test injection.
In particular embodiments, the force sensor 130a is a FlexiForce A201 sensor
(Tekscan, Inc., South Boston, MA, USA) that senses between 0-25 lbs of force with a
sensing area diameter of .375 inches. Any suitable force sensor can be used, for
example, sensors can be used that operate within a general dynamic force range for an
injection (e.g., about 2-3 lbs. of force) and with a sensing area that is sufficiently
small to be mounted to the top of the syringe plunger 115a.
In particular embodiments, the displacement sensor 130b is an S-VDRT, 38
mm range displacement transducer (MicroStrain, Williston, Vermont, USA), which
measures sufficient displacement of the plunger 115a while being sufficiently small to
be mounted on the syringe 115.
The sensors 130a, 130b can be attached to a circuit and/or software to
manipulate data and/or provide a user feedback indicator member 22, e.g., to convert
voltage readings from the sensors into units of force and displacement, respectively.
Exemplary force and displacement sensor calibrations are illustrated in Figures 7 and
8, respectively.
Force and displacement were measured and recorded throughout numerous
injections performed in pig tissue on a pig hoof. The data was recorded and used to
calculate the pressure and flow-rate during the injections. The maximum pressure
during each injection was divided by the average flow-rate of the same injection to
calculate an impedance value. As can be seen in Figures 9-11 and in Tables 1-2
(below), the fluid flow impedance is generally lower in joint tissue than in other tissue
areas. When injecting into an area other than the joint, the average maximum force
and pressure were more than twice that of when injecting into the joint. The average
flow-rate while injecting into joints was over three times that of tendons. The higher
pressure and lower flow-rate of the tendon injections indicates that there is generally
higher impedance in these types of tissues compared to joints, which exhibit generally
lower pressures and higher flow-rates. When impedance is compared between the
two locations, impedance in a tendon is over 550 times that of a joint if all trials are
included. Even if the outlying tendon impedance values are omitted, the impedance
value of the tendon is over 20 times that of the joint.
Table 1; Avera e Joint Values
Example 2
With reference to Figures 1-3, in particular exemplary embodiments, the
sensors 30 are a pressure transducer and/or flow sensor that comes into physical
contact with the fluid in the syringe body 15b. For example, a pressure and/or flow
sensor can be provided in the housing 20 between the needle 25 and the syringe body
15b such that the housing provides a fluid channel that can be generally the same
diameter as the fluid channel adjacent the needle such that alteration of the syringe 15
is reduced. Fluid impedance can be tested by a user by inserting the needle 25 into
the tissue Tl, T2 and T3 and then injecting a relatively small amount of fluid into the
tissue Tl, T2 and T3. The pressure and flow readings from the sensors 30 can then
be converted into impedance, e.g., by the computer device 23 and relayed to the user
via the user feedback indicator member 22.
Example 3
With continued reference to Figures 1-3, the sensor(s) 30 are force and/or
pressure sensors that measure the impedance or force/pressure on the needle 25 during
insertion into the tissue Tl, T2, T3. For example, the sensor(s) 30 can be
piezoelectric or other suitable force sensors positioned on the needle to detect force as
a function of time during needle insertion. In particular embodiments, the force
and/or pressure sensor(s) 30 can be in communication with the needle 25 and/or the
sensor(s) can detect a deforming force on the needle 25. The force applied to the
needle 25 (or on the syringe 15) can be measured while the needle 25 is inserted into
the tissue Tl, T2, T3. Generally continuous force readings may be taken, and a force
curve may be created. For example, the user may apply constant force during
insertion, and then the force may drop when the needle 25 reaches the joint cavity
tissue T3. The computer device 23 may be configured to detect the reduction in force
when the needle 25 reaches the joint cavity tissue T3 and relay the feedback to the
user via the user feedback indicator member 22.
The foregoing is illustrative of the present invention and is not to be construed
as limiting thereof. Although a few exemplary embodiments of this invention have
been described, those skilled in the art will readily appreciate that many modifications
are possible in the exemplary embodiments without materially departing from the
novel teachings and advantages of this invention. Accordingly, all such modifications
are intended to be included within the scope of this invention as defined in the claims.
The invention is defined by the following claims, with equivalents of the claims to be
included therein.
THAT WHICH IS CLAIMED:
1. A syringe system comprising:
a syringe with a syringe body defining a fluid cavity in fluid communication
with an injection needle;
a pressure, force and/or flow sensor in fluid communication with the needle;
and
a user feedback unit in electrical communication with the sensor and
configured to provide user feedback based on data from the pressure, force and/or
flow sensor.
2. A syringe system according to Claim 1, wherein the user data feedback unit
comprises a housing having a light indicator whereby in operation the housing
generates a light if the needle is in a suitable location for injection.
3. A syringe system according to Claim 2, wherein the housing is configured
to releasably engage the syringe body.
4. A syringe system according to Claim 3, wherein the housing is configured
to slidably snugly receive a portion of the syringe therein.
5. A syringe system according to Claim 2, wherein the housing comprises a
digital signal processor circuit configured to calculate an index of resistance
associated with the location of the needle in a patient with a low index of resistance
indicating a desired injection site.
6. A syringe system according to Claim 5, further comprising a portable
computer device in communication with the sensor and the housing to
programmatically direct the output of the user feedback unit.
7. A syringe system according to Claim 5, wherein the sensor is configured to
wirelessly communicate with the digital signal processor circuit.
8. A syringe system according to Claim 6, wherein the sensor and the user
feedback unit are configured to wirelessly communicate with the digital signal
processor circuit.
9. A syringe system according to Claim 2, wherein the housing is serially
reusable with different syringes and a respective syringe is single-use disposable.
10. A syringe system according to Claim 1, wherein the syringe is a teaching
syringe for teaching a user to associate a tactile excursion feel associated with a low
index of resistance.
11. A syringe system according to Claim 1, wherein the syringe is configured
and sized as an orthopedic tool to deliver medicament accurately to a target joint
space of an arthritic patient.
12. A syringe system according to Claim 1, wherein the syringe comprises a
plunger, and the pressure and/or flow sensor comprises a plunger force sensor
configured to detect a force exerted on the plunger by a user and a displacement
sensor configured to detect a displacement of the plunger.
13. A syringe system according to Claim 12, wherein the user feedback unit
comprises a digital signal processor circuit configured to calculate an index of
resistance based on the force exerted on the plunger and the displacement of the
plunger with a low index of resistance indicating a desired injection site.
14. A syringe system according to Claim 13, wherein the index of resistance
is based on a test injection.
15. A syringe system according to Claim 12, wherein the user data feedback
unit comprises a housing configured to releasably attach to the plunger of the syringe
and to having the plunger force sensor and displacement sensor thereon.
16. A syringe system according to Claim 1, wherein the pressure and/or flow
sensor comprises a fluid pressure sensor and a flow meter.
17. A syringe system according to Claim 1, wherein the force, pressure and/or
flow sensor comprises a force sensor configured to detect a force on a portion of the
syringe as a user inserts the injection needle into tissue of a patient.
18. A syringe system according to Claim 1, wherein the user feedback unit is
attached to the syringe body.
19. A syringe system comprising:
a syringe with a syringe body defining a fluid cavity and having a plunger in
the fluid cavity, the fluid cavity being in fluid communication with an injection
needle;
a plunger force sensor configured to detect a force exerted on the plunger by a
user;
a displacement sensor configured to detect a displacement of the plunger; and
a user feedback unit in electrical communication with the plunger force sensor
and the displacement sensor and configured to provide user feedback based on data
from the pressure and/or flow sensor.
20. A syringe system according to Claim 19, wherein the user data feedback
unit comprises a housing having a light indicator whereby in operation the housing
generates a light if the needle is in a suitable location for injection.
21. A syringe system according to Claim 20,wherein the housing is configured
to releasably engage the syringe body.
22. A syringe system according to Claim 21, wherein the housing is
configured to slidably snugly receive a portion of the syringe therein.
23. A syringe system according to Claim 20, wherein the housing comprises a
digital signal processor circuit configured to calculate an index of resistance
associated with the location of the needle in a patient with a low index of resistance
indicating a desired injection site.
24. A syringe system according to Claim 23, further comprising a portable
computer device in communication with the sensor and the housing to
programmatically direct the output of the user feedback unit.
25. A syringe system according to Claim 23, wherein the sensor is configured
to wirelessly communicate with the digital signal processor circuit.
26. A syringe system according to Claim 24, wherein the sensor and the user
feedback unit are configured to wirelessly communicate with the digital signal
processor circuit.
27. A syringe system according to Claim 21, wherein the housing is serially
reusable with different syringes and a respective syringe is single-use disposable.
28. A syringe system according to Claim 20, wherein the syringe is a teaching
syringe for teaching a user to associate a tactile excursion feel associated with a low
index of resistance.
29. A syringe system according to Claim 20, wherein the syringe is configured
and sized as an orthopedic tool to deliver medicament accurately to a target joint
space of an arthritic patient.
30. A syringe system according to Claim 20, wherein the user feedback unit
comprises a digital signal processor circuit configured to calculate an index of
resistance based on the force exerted on the plunger and the displacement of the
plunger with a low index of resistance indicating a desired injection site.
31. A syringe system according to Claim 29, wherein the index of resistance
is based on a test injection.
32. A syringe system according to Claim 30, wherein the user data feedback
unit comprises a housing configured to releasably attach to the plunger of the syringe
and to having the plunger force sensor and displacement sensor thereon.
33. A syringe system according to Claim 1, wherein the user feedback unit is
attached to the syringe body.
34. A syringe sensor system configured to releasably attach to a syringe with a
syringe body defining a fluid cavity and having a plunger in the fluid cavity, the fluid
cavity being in fluid communication with an injection needle, the syringe sensor
system comprising:
at least one housing configured to releasably attach to the syringe;
a plunger force sensor on the at least one housing and configured to detect a
force exerted on the plunger by a user;
a displacement sensor on the at least one housing and configured to detect a
displacement of the plunger; and
a user feedback unit in electrical communication with the plunger force sensor
and the displacement sensor and configured to provide user feedback based on data
from the force and/or flow sensor.
35. A method for selecting a tissue region for injection with a syringe in
communication with an injection needle, the method comprising:
detecting a force, pressure and/or flow associated with the syringe and/or
injection needle during insertion of the needle and/or during injection of a fluid
through the needle; and







A. CLASSIFICATION OF SUBJECT MATTER
INV. A61M5/48 A61M5/32 A61B17/34
ADD. A61M5/315 . A61M5/42 A61M5/28
According to International Patent Classification (IPC) o r to both national classification and IPC
B. FIELDS SEARCHED
Minimum documentation searched (classification system followed by classification symbols)
A61M A61B
Documentation searched other than minimum documentation to the extent that such documents are included in the fields searched
Electronic data base consulted duπng the international search (name of data base and, where practical, search terms used)
EPO-Internal , WPI Data
c. DOCUMENTS CONSIDERED TO BE RELEVANT
Category * Citation of document, with indication, where appropriate, of the relevant passages Relevant to claim No.
WO 2005/027992 A (MILESTONE SCIENT INC 1-16,
[US]) 31 March 2005 (2005-03-31) 18-34
page 7 , lines 1-17; figures 1-10
page 9 , line 2 - page 10, line 13 17
page 11, line 13 - page 25, line 21
EP 0 538 259 A (PALEX IND SA [ES]) 1,2,5-8,
28 April 1993 (1993-04-28) 11
column 7 , line 1 - column 8 , line 37;
figures 1-3
WO 2004/082491 A (GANZ ROBERT [US]; 1,2,5-8,
ZELICKSON BRIAN [US]; RYDELL MARK [US]) 11
30 September 2004 (2004-09-30)
page 5 , line 23 - page 6 , line 28; claims
1-7; figures la-3
-/--
Further documents are listed in the continuation of Box C See patent family annex.
* .Special categories of cited documents :
'T' later document published after the international filing date
or priority date and not in conflict with the application but1A1 document defining the general state of the art which is not cited to understand the principle or theory underlying the
considered to be of particular relevance invention
1E" earlier document but published on or after the international 'X' document of particular relevance; the claimed invention
filing date cannot be considered novel or cannot be considered to
'L' document which may throw doubts on priority claim(s) or involve an inventive step when the document is taken alone
which is cited to establish the publication date of another 'Y' document of particular relevance; the claimed invention
citation or other special reason (as specified) cannot be considered to involve an inventive step when the
O * document referring to an oral disclosure, use, exhibition or document is combined with one or more other such docu¬
other means ments, such combination being obvious to a person skilled
'P' document published prior to the international filing date but in the art.
later than the priority date claimed •&' document member of the same patent family
Date of the actual completion of the international search Date of mailing of the international search report
28 November 2008 08/12/2008
Name and mailing address of the ISA/ Authorized officer
European Patent Office, P.B. 5818 Patentlaan 2
NL - 2280 HV Rijswijk
TeI. (+31-70) 340-2040,
Fax; (+31-70) 340-3016 Bj δrkl und, Andreas
Form PCT/ISA/210 (second sheet) (April 2005)
C(Contlnuatιon). DOCUMENTS CONSIDERED TO BE RELEVANT
Category Citation of document, with indication, where appropriate, of the relevant passages Relevant to claim No
US 5 270 685 A (HAGEN RONALD W [US] ET AL) 1-5,
14 December 1993 (1993-12-14) 9-11,14,
18
column 2 , line 28 - column 3 , line 27; 12,13,
figures 1-9 15,16,
19-34
EP 0 635 277 A (HAMILTON CO [US]) 1-5,
25 January 1995 (1995-01-25) 9-11,14
column 6 , lines 31-54; figures 1-10 12,13,
15,16,
19-34
column 9 , line 15 - column 11, line 15
US 4 535 773 A (YOON INBAE [US] ET AL) 17
20 August 1985 (1985-08-20)
column 15, line 64 - column 17, line 1 ; 6-8,
figure 34 24-26
column 19, lines 30-45
WO 2005/046559 A (LIFESCAN INC [US]; VEIT 6-8,
ERIC D [US]; BYLUND ADAM [US]; WEBER BARRY 24-26
[US) 26 May 2005 (2005-05-26)
paragraphs [0033], [0034]; figures 1-4
US 5 517 846 A (CAGGIANI CARLOS A [US]) 1-34
21 May 1996 (1996-05-21)
abstract; figures 1A-2
Form PCT/ISA/210 (continuation of second sheet) (Aoπl 2005)
International application No.
INTERNATIONAL SEARCH REPORT PCT/US2008/009722
Box No. Il Observations where certain claims were found unsearchable (Continuation of item 2 of first sheet)
This international search report has not been established in respect of certain claims under Article 17(2)(a) for the following reasons:
1. JM Claims Nos.: 3 5
because they relate to subject matter not required to be searched by this Authority, namely:
The subject-matter of claim 35 defines a method comprising the step of
inserting a needle. Implicitly the needle is inserted into patient. This is a
method for treatment of the human or animal body by surgery (Rule 39. l(i v )
PCT).
2. Claims Nos.:
because they relate to parts of the international application that do not comply with the prescribed requirements to such
an extent that no meaningful international search can be carried out, specifically:
3. J Claims Nos.:
because they are dependent claims and are not drafted in accordance with the second and third sentences of Rule 6.4(a).
Box No. Ill Observations where unity of invention is lacking (Continuation of item 3 of first sheet)
This International Searching Authority found multiple inventions in this international application, as follows.
As all required additional search fees were timely paid by the applicant, this international search report covers allsearchable
claims.
2. As all searchable claims could be searched without effort justifying an additional fees, this Authority did not invite payment of
additional fees.
3. As only some of the required additional search fees were timely paid by the applicant, this international search reportcovers
only those claims for which fees were paid, specifically claims Nos.:
4. I I No required additional search fees were timely paid by the applicant. Consequently, this international search report is
restricted to the invention first mentioned in the claims; it is covered by claims Nos.:
Remark on Protest The additional search fees were accompanied by the applicant's protest and, where applicable, the
'— ' payment of a protest fee.
The additional search fees were accompanied by the applicant's protest but the applicable protest
fee was not paid within the time limit specified in the invitation.
No protest accompanied the payment of additional search fees.
Form PCT/ISA/210 (continuation of first sheet (2)) (April 2005)
Patent document Publication Patent family Publication
cited in search report date member(s) date
WO 2005027992 A 31-03-2005 BR PI0414352 A 14-11-2006
CA 2539106 Al 31-03-2005
EP 1670522 A2 21-06-2006
J P 2007504907 T 08-03-2007
KR ..0060121916 A 29-11-2006
MX PA06002764 A 14-06-2006
EP 0538259 A 28-04-1993 EP 0536138 A2 14-04-1993
WO 9215256 Al 17-09-1992
WO 2004082491 A 30-09-2004 NONE
US 5270685 A 14-12-1993 AT 192869 T 15-05-2000
AU 658793 B2 27-04-1995
AU 2271292 A 11-02-1993
CA 2110818 Al 21-01-1993
DE 69231037 Dl 15-06-2000
DE 69231037 T2 02-11-2000
EP 0612425 Al 31-08-1994
ES 2146587 T3 16-08-2000
J P 6509006 T 13-10-1994
WO 9301573 Al 21-01-1993
EP 0635277 A 25-01-1995 AT 209052 T 15-12-2001
CA 2126934 Al 31-12-1994
DE 69429136 Dl 03-01-2002
US 5611784 A 18-03-1997
US 4535773 A 20-08-1985 NONE
WO 2005046559 A 26-05-2005 AU 2004286716 Al 21-07-2005
CA 2511746 Al 26-05-2005
CN 1871046 A 29-11-2006
EP 1680175 A2 19-07-2006
J P 2007510469 T 26-04-2007
KR 20060132434 A 21-12-2006
US 2005182358 Al 18-08-2005
US 5517846 A 21-05-1996 NONE
Form PCT/ISA/210 (patent family annex) (April 2005)
